Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Important Mixing Guidelines Inject the bacteriostatic water slowly down the side of the vial Do not spray the water directly onto the peptide powder Allow the peptide to dissolve naturally Swirl gently if needed do not shake the vial Shaking may damage the delicate peptide structure Once fully mixed, the solution should appear clear and free of visible particles Use sterile handling practices and avoid repeated contamination of the vial Storage Guidelines Store the unmixed lyophilized vial in a cool, dark place After reconstitution, refrigerate at 28C Avoid direct sunlight and repeated heat exposure Keep the vial sealed and sterile between uses Research Administration Guide Typical Research Protocol Begin with the lowest effective research amount Many research protocols begin at 2.5mg once weekly for approximately 4 weeks Administration amounts are commonly adjusted approximately every 4 weeks depending on response and tolerability Some research protocols maintain lower administration amounts for extended periods if desired research outcomes remain consistent Gradual administration escalation is commonly utilized to support tolerability and minimize gastrointestinal side effects Typically researched as a once-weekly peptide Important Notice This product is supplied strictly for laboratory and research purposes only
PlexusDx Weight Management Protocols are focused on semaglutide and tirzepatide pathways with provider evaluation included, not retatrutide
BPC-157 is one of the most extensively referenced cytoprotective peptides, with studies spanning gastrointestinal, musculoskeletal, cardiovascular, and central nervous system research contexts
Do not apply to broken skin
This makes stepping down from higher doses a viable strategy if side effects prove difficult
Semaglutide : Also highly effective, helping patients achieve an average weight loss of 1520% when combined with lifestyle changes
